Main navigation

Diabetes Injection Pens Market

Diabetes Injection Pens Market Forecast, Trend Analysis & Competition Tracking - Global Industry Insights 2015 to 2031

  • 23410

  • Feb 2022

  • 189

  • PDF

    • ★★★★★
      ★★★★★
    • (37)
  • Our Research Methodology is based on the following main points:
    1. Data Collections and Interpretation
    2. Analysis
    3. Data Validation
    4. Final Projections and Conclusion

Select License

  • It allows one person, the buyer, to have sole right and access to the purchased report. Further distribution of product is strictly prohibited.
  • It allows the purchased product to be shared among 5 people within your organization at maximum.
  • It allows the purchased product to be shared among all employees of your organization irrespective of their geographical location.
Request sample

  • An insulin pen is a medical device used to inject insulin. There are two types of pens available in the market; disposable and reusable. A disposable injection pen contains a prefilled insulin and is thrown away after use. A reusable injection pen has an insulin cartridge; when the cartridge is empty, a new prefilled cartridge can be inserted in it.

    Request Covid - 19 Impact

    Details About Top-Selling Insulin Pens, 2020

    • NOVO NORDISK TRESIBA FLEXTOUCH

    Disposable

    INSULINS Tresiba U-100 Tresiba U-200

    DOSE DELIVERY for U-100: 1-unit increments, up to 80 units at a time. For U-200: 2-unit increments, up to 160 units at a time.

    TOTAL CAPACITY for U-100: 300 units For U-200: 600 units

    DETAILS Pen is dark blue with a light green (U-100) or dark green (U-200) label. The spring-loaded mechanism requires less force for dose delivery. This includes a non-extending dose button. There is an audible click at the end of the dose, but to ensure the full dose is delivered, keep the needle under the skin and the dose button depressed after the dose counter returns to zero, then slowly count to six.

    • NOVO NORDISK NOVOLOG FLEXPEN

    Disposable

    INSULINS NovoLog Mix 70/30

    DOSE DELIVERY 1-unit increments, up to 60 units at a time

    TOTAL CAPACITY 300 units

    DETAILS Pen is blue, with different colored labels, cartridge holders, and dosing knobs for various types of insulin. Dial returns to zero after injection to indicate delivery.

    • SANOFI LANTUS SOLOSTAR

    Disposable

    INSULIN Lantus DOSE DELIVERY 1-unit increments, up to 80 units at a time

    TOTAL CAPACITY 300 units

    DETAILS Pen is gray.

    • ELI LILLY HUMALOG JUNIOR KWIKPEN

    Disposable

    INSULIN Humalog U-100

    DOSE DELIVERY Half-unit increments, up to 30 units at a time

    TOTAL CAPACITY 300 units

    DETAILS Pen is blue with an orange label.

    • ELI LILLY HUMULIN KWIKPEN

    Disposable

    INSULINS Humulin N Humulin 70/30 Humulin R U-500

    DOSE DELIVERY for all except U-500: 1-unit increments, up to 60 units at a time. For U-500: 5-unit increments, up to 300 units at a time.

    TOTAL CAPACITY for all except U-500: 300 units. For U-500: 1,500 units.

    DETAILS Humulin N and Humulin 70/30 pens are beige, with different colored labels and dosing knobs. The U-500 pen is aqua.

    Global Diabetes Injection Pens Market Revenue Outlook:

    The global diabetes injection pens market was valued at US$ 22.2 Bn in 2018 and is projected to register а САGR of 4.8% by 2031.

    Nonetheless, various industry players in the global Diabetes Injection Pens market are now increasing their focus towards the establishment of successful collaborations, acquisitions, and joint venture activities as a means to enhance their respective customer bases. In doing so, these players are also increasing their supply capabilities to meet customer requirements on a local and global scale. This factor, paired with promising industrialization prospects in developing economies of the Asia-Pacific region, such as China, India, Taiwan, Indonesia, etc., are expected to create massive business opportunities for key players over the forecast period.

    FDA Approved Diabetes Injection Pens:

    Brand NameOther NamesType of Insulin
    AdmelogInsulin Lispro InjectionRapid-Acting
    Apidra SolostarInsulin GlulisineRapid-Acting
    Fiasp FlextouchInsulin AspartRapid-Acting
    Humalog KwikpenInsulin LisproRapid-Acting
    NovologInsulin AspartRapid-Acting
    Humulin R PenRegular Human InsulinShort-Acting
    Novolin RRegular Human InsulinShort-Acting
    Humulin NNPH Human InsulinIntermediate-Acting
    Novolin NNPH Human InsulinIntermediate-Acting
    Basaglar KwikPenInsulin GlargineLong-Acting
    Lantus SolostarInsulin GlargineLong-Acting
    LevemirInsulin DetemirLong-Acting
    Toujeo MaxInsulin GlargineLong-Acting
    Tresiba FlexTouchInsulin DegludecLong-Acting
    Humalog Mix 75/25 KwikPen75% Insulin Lispro Protamine SuspensionIntermediate- and Rapid-Acting
    25% Insulin Lispro Injection
    Humalog 70/3070% Human Insulin Isophane SuspensionIntermediate- and Rapid-Acting
    Humalog Mix 50/50 KwikPen50% Insulin Lispro Protamine Suspension
    50% Insulin Lispro InjectionIntermediate- and Rapid-Acting
    NovoLog Mix 70/30 FlexPen70% Insulin Aspart Protamine Suspension
    30% insulin aspart injection30% Insulin Aspart InjectionIntermediate- and Rapid-Acting
    Ryzodeg 70/30 FlexTouch70% Insulin DegludecLong- and Rapid-Acting
    30% Insulin Aspart
    Humulin 70/30 KwikPen70% NPH Human Insulin
    30% Regular Human Insulin InjectionIntermediate- and Short-Acting
    Novolin 70/3070% Nph Human InsulinIntermediate- and Short-Acting
    30% Regular Human Insulin Injection

    To learn more about this report, request for sample report

    How Is The Demand For Diabetes Injection Pens Increasing?

    Patient pool suffering from type 1 and type 2 diabetes across the globe.  The number of cases and the prevalence of diabetes have been steadily increasing over the past few decades. Treatment for diabetes includes insulin which is a hormone that helps in regulating blood glucose. Treatment depends on the type of diabetes.

    • According to a WHO 2018 report, about 422 Mn people worldwide have diabetes, the majority living in low-and middle-income countries, and approximately 1.6 Mn deaths are due to diabetes each year.
    • The number of diabetics worldwide in 2019 was 463 million and is expected to reach 700 million by 2045. With an increased number of diabetics, the prevalence of diabetes is also projected to increase to almost 11 percent by 2045.

    Top-Selling Diabetes Injection Pens In 2021

    • Owen Mumford Autopen
    • Humapen Memoir
    • Humalog U-100 Kwikpen
    • Novo Nordisk NovoPen 4
    • HumaPen Luxura HD
    • Novo Nordisk NovoPen Echo
    • Lantus Solostar
    • Novo Nordisk FlexPen
    • Novo Nordisk Tresiba Flextouch
    • Humalog U-200 KwikPen

    The World’s Top Selling Diabetes Drugs

    • Lantus (insulin glargine [rDNA origin] injection)
    • Januvia (Sitagliptin 25mg, 50mg, 100mg tablets)
    • NovoLog (insulin aspart [rDNA origin] injection)
    • Humalog (insulin lispro protamine suspension and insulin lispro injection [rDNA origin])
    • Levemir (insulin detemir (rDNA origin) injection)
    • Victoza (liraglutide (rDNA origin) injection)
    • Janumet (sitagliptin and metformin)
    • Humulin (insulin isophane and insulin regular injection)
    • Galvus (vildagliptin)
    • Onglyza (saxagliptin)

    Effects Of An Alternative Mode Of Drug Delivery On Diabetes Injection Pens Market

    Commercially there are many alternatives for diabetes injection pens available in the market such as nasal insulin, artificial pancreas, bionic pancreas, and others. This alternative may hamper the growth of the diabetes injection pen market to a certain extent. Shifting patient preferences towards needle-free drug delivery technology are expected to affect the market's growth significantly.

    Country-Wise Analysis

    Why Is The Demand For Diabetes Injection Pens High In North America?

    The prevalence rate of chronic diseases such as diabetes, cardiovascular diseases, multiple sclerosis has increased in countries such as the U.S. and Canada. For the administration of drugs, patients are looking for an easy and hassle-free mode of drug dose delivery; these are the factors up surging the demand for diabetes injection pens.

    • According to the National Diabetes Statistics Report, 2020, published by the U.S. Department of Health & Human Services, new diabetes cases have increased over the last decade. Approximately 34.2 million people of all ages, or 10.5% of the U.S. population, had diabetes.

    Segment-Wise Analysis

    Why Are Disposable Injection Pens More Preferred?

    By type, demand for disposable injection pens is expected to register a high growth rate until 2031, owing to ease of use and less chance of cross-contamination during insulin administration. Growing awareness among healthcare professionals and patients is further expected to fuel the growth of the target market.

    Competitive Landscape

    The diabetes injection pens landscape appears highly consolidated, with a major chunk of it being dominated by the U.S. players.

    • AstraZeneca PLC
    • Becton, Dickinson, and Company
    • Biocon Ltd.
    • Eli Lilly and Company
    • Jiangsu Delfu medical device Co., Ltd.
    • Novo Nordisk A/S
    • Owen Mumford Ltd.
    • Wockhardt Ltd.
    • SANOFI
    • Other Players

    Some Notable Developments In The Market Include:

    • In April 2021, under BioCorp and Roche's partnership, the company launched Mallya – smart insulin pen in France. The product has C.E. mark approval in Europe. The smartpen helps in monitoring the doses selected for injection with diabetes for better compliance with their treatment.
    • In November 2020, Medtronic plc, an Ireland–based company, launched InPen, integrated with real-time Guardian Connect CGM data. InPen is the 1st and only FDA-cleared smart insulin pen in the market for people on multiple daily injections (MDI).
    • In August 2020, Biocon Biologics and Mylan launched a new product Semglee – insulin glargine injection in a vial and prefilled pen. This product is approved to help control high blood sugar in adult and pediatric patients with type 1 diabetes and adults with type 2 diabetes patients.

    Report Scope

    • Forecast Period: 2022-2031
    • Actual Year: 2021
    • Historical Data Available for: 2015-2020

    Key Regions Covered

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

    Key Segments Covered

    Diabetes Injection Pens Market, By Type

    • Disposable Injection Pens
    • Reusable Injection Pens

    Diabetes Injection Pens Market, By Distribution Channel

    • Retail Pharmacies
    • Online Medical Stores
    • Diabetes Clinics
    • Other Distribution Channel

    Diabetes Injection Pens Market, By End Users

    • Hospitals & Clinics
    • Home Care
    AttributeReport Details
    Market Size Ask For Market Size
    Growth Rate Ask For Growth Rate
    Key Companies Ask For Companies
    Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more…
    Historical Data Period 2015-2020
    Base Year 2022
    Forecast Period 2022-2031
    Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa
    Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
    Revenue inUS$ Mn

    To learn more about this report, request for sample report

    • Novo Nordisk A/S
    • Eli Lilly and Company
    • AstraZeneca plc
    • Biocon Ltd.
    • Sanofi S.A.
    • Becton
    • Dickinson and Company
    • Owen Mumford Ltd.
    • Jiangsu Delfu Co. and Wockhardt Ltd.
    • Chapter 1 Global Diabetes Injection Pens Market Outlook
      • 1.1 Introduction
      • 1.2 Segmentation of Diabetes Injection Pens Market Based On Type, Dristribution Channel, End User and Region
      • 1.3 Market Drivers
      • 1.4 Market Restraints
      • 1.5 Market Opportunities
      • 1.6 Market Trends
      • 1.7 Macro-economic Factors
      • 1.8 Regulatory Framework
      • 1.9 Global Diabetes Injection Pens Market Pricing Analysis by Region, 2021
      • 1.10 Opportunity Map Analysis
        • 1.10.1 Optimistic Scenario
        • 1.10.2 Likely Scenario
        • 1.10.3 Conservative Scenario
      • 1.11 Opportunity Orbits
      • 1.12 Market Investment Feasibility Index
      • 1.13 PEST Analysis
      • 1.14 PORTER’S Five Force Analysis
      • 1.15 Drivers & Restraints Impact Analysis
      • 1.16 Marketing Strategy
      • 1.17 Product Life Cycle Analysis
      • 1.18 Value Chain Analysis
      • 1.19 Cost Structure Analysis
      • 1.20 Regional Market Share and BPS Analysis in Diabetes Injection Pens Market
      • 1.21 COVID-19 Impact Analysis
    • Chapter 2 Global Diabetes Injection Pens Market Overview
      • 2.1 Global Market Value & Volume Comparison by Type (2015-2031)
        • 2.1.1 Global Market Value & Volume Market Share by Type in 2021
        • 2.1.2 Global Market Attractiveness Analysis by Type, 2015–2022
      • 2.2 Global Market Value & Volume Comparison by Dristribution Channel (2015-2031)
        • 2.2.1 Global Market Value & Volume Market Share by Dristribution Channel in 2021
        • 2.2.2 Global Market Attractiveness Analysis by Dristribution Channel, 2015–2022
      • 2.3 Global Market by End User
        • 2.3.1 Global Market Value & Volume Comparison by End User (2015-2031)
        • 2.3.2 Global Market Value & Volume Market Share by End User in 2021
        • 2.3.3 Global Market Attractiveness Analysis by End User, 2015–2022
      • 2.4 Global Market Outlook by Region
        • 2.4.1 Global Market Value & Volume Comparison by Region (2015-2031)
        • 2.4.2 Global Market Value & Volume Market Share by Region in 2021
        • 2.4.3 Global Market Attractiveness Analysis by Region, 2015–2022
      • 2.5 Global Market Outlook (2015-2031)
        • 2.5.1 Global Market Value & Volume (2015–2022)
        • 2.5.2 Global Market Value & Volume (2023-2031)
      • 2.6 Global Market Value & Volume by Regions
        • 2.6.1 Global Market Value & Volume Comparison by Region (2015–2022)
        • 2.6.2 Global Market Value & Volume Comparison by Region (2023-2031)
      • 2.7 Global Market Value & Volume by Type
        • 2.7.1 Global Market Value & Volume Comparison by Type (2015–2022)
        • 2.7.2 Global Market Value & Volume Comparison by Type (2023-2031)
      • 2.8 Global Market Value & Volume by Dristribution Channel
        • 2.8.1 Global Market Value & Volume Comparison by Dristribution Channel (2015–2022)
        • 2.8.2 Global Market Value & Volume Comparison by Dristribution Channel (2023-2031)
      • 2.9 Global Market Value & Volume by End User
        • 2.9.1 Global Market Value & Volume Comparison by End User (2015–2022)
        • 2.9.2 Global Market Value & Volume Comparison by End User (2023-2031)
      • 2.10 Global Market Y-o-Y Growth Rate Comparison 2016–2031
        • 2.10.1 Global Market Y-o-Y Growth Rate by Region
        • 2.10.2 Global Market Y-o-Y Growth Rate by Type
        • 2.10.3 Global Market Y-o-Y Growth Rate by Dristribution Channel
        • 2.10.4 Global Market Y-o-Y Growth Rate by End User
      • 2.11 Global Market Share Comparison 2015–2030
        • 2.11.1 Global Market Share by Region
        • 2.11.2 Global Market Share by Type
        • 2.11.3 Global Market Share by Dristribution Channel
        • 2.11.4 Global Market Share by End User
    • Chapter 3 North America Diabetes Injection Pens Market Overview
      • 3.1 North America Market by Type
        • 3.1.1 North America Market Value & Volume Comparison by Type (2015-2031)
        • 3.1.2 North America Market Value & Volume Market Share by Type in 2021
      • 3.2 North America Market Value & Volume Comparison by Dristribution Channel (2015-2031)
        • 3.2.1 North America Market Value & Volume Market Share by Dristribution Channel in 2021
        • 3.2.2 North America Market Attractiveness Analysis by Dristribution Channel, 2015–2022
      • 3.3 North America Market by End User
        • 3.3.1 North America Market Value & Volume Comparison by End User (2015-2031)
        • 3.3.2 North America Market Value & Volume Market Share by End User in 2021
        • 3.3.3 North America Market Attractiveness Analysis by End User, 2015–2022
      • 3.4 North America Market Outlook by Region
        • 3.4.1 North America Market Value & Volume Comparison by Region (2015-2031)
        • 3.4.2 North America Market Value & Volume Market Share by Region in 2021
        • 3.4.3 North America Market Attractiveness Analysis by Region, 2015–2022
      • 3.5 North America Market Outlook (2015-2031)
        • 3.5.1 North America Market Value & Volume (2015–2022)
        • 3.5.2 North America Market Value & Volume (2023-2031)
      • 3.6 North America Market Value & Volume by Regions
        • 3.6.1 North America Market Value & Volume Comparison by Region (2015–2022)
        • 3.6.2 North America Market Value & Volume Comparison by Region (2023-2031)
      • 3.7 North America Market Value & Volume by Type
        • 3.7.1 North America Market Value & Volume Comparison by Type (2015–2022)
        • 3.7.2 North America Market Value & Volume Comparison by Type (2023-2031)
      • 3.8 North America Market Value & Volume by Dristribution Channel
        • 3.8.1 North America Market Value & Volume Comparison by Dristribution Channel (2015–2022)
        • 3.8.2 North America Market Value & Volume Comparison by Dristribution Channel (2023-2031)
      • 3.9 North America Market Value & Volume by End User
        • 3.9.1 North America Market Value & Volume Comparison by End User (2015–2022)
        • 3.9.2 North America Market Value & Volume Comparison by End User (2023-2031)
      • 3.10 North America Market Y-o-Y Growth Rate Comparison 2016–2031
        • 3.10.1 North America Market Y-o-Y Growth Rate by Region
        • 3.10.2 North America Market Y-o-Y Growth Rate by Type
        • 3.10.3 North America Market Y-o-Y Growth Rate by Dristribution Channel
        • 3.10.4 North America Market Y-o-Y Growth Rate by End User
      • 3.11 North America Market Share Comparison 2015–2030
        • 2.11.1 North America Market Share by Region
        • 3.11.2 North America Market Share by Type
        • 3.11.3 North America Market Share by Dristribution Channel
        • 3.11.4 North America Market Share by End User
    • Chapter 4 Europe Diabetes Injection Pens Market Overview
      • 4.1 Europe Market by Type
        • 4.1.1 Europe Market Value & Volume Comparison by Type (2015-2031)
        • 4.1.2 Europe Market Value & Volume Market Share by Type in 2021
      • 4.2 Europe Market Value & Volume Comparison by Dristribution Channel (2015-2031)
        • 4.2.1 Europe Market Value & Volume Market Share by Dristribution Channel in 2021
        • 4.2.2 Europe Market Attractiveness Analysis by Dristribution Channel, 2015–2022
      • 4.3 Europe Market by End User
        • 4.3.1 Europe Market Value & Volume Comparison by End User (2015-2031)
        • 4.3.2 Europe Market Value & Volume Market Share by End User in 2021
        • 4.3.3 Europe Market Attractiveness Analysis by End User, 2015–2022
      • 4.4 Europe Market Outlook by Region
        • 4.4.1 Europe Market Value & Volume Comparison by Region (2015-2031)
        • 4.4.2 Europe Market Value & Volume Market Share by Region in 2021
        • 4.4.3 Europe Market Attractiveness Analysis by Region, 2015–2022
      • 4.5 Europe Market Outlook (2015-2031)
        • 4.5.1 Europe Market Value & Volume (2015–2022)
        • 4.5.2 Europe Market Value & Volume (2023-2031)
      • 4.6 Europe Market Value & Volume by Regions
        • 4.6.1 Europe Market Value & Volume Comparison by Region (2015–2022)
        • 4.6.2 Europe Market Value & Volume Comparison by Region (2023-2031)
      • 4.7 Europe Market Value & Volume by Type
        • 4.7.1 Europe Market Value & Volume Comparison by Type (2015–2022)
        • 4.7.2 Europe Market Value & Volume Comparison by Type (2023-2031)
      • 4.8 Europe Market Value & Volume by Dristribution Channel
        • 4.8.1 Europe Market Value & Volume Comparison by Dristribution Channel (2015–2022)
        • 4.8.2 Europe Market Value & Volume Comparison by Dristribution Channel (2023-2031)
      • 4.9 Europe Market Value & Volume by End User
        • 4.9.1 Europe Market Value & Volume Comparison by End User (2015–2022)
        • 4.9.2 Europe Market Value & Volume Comparison by End User (2023-2031)
      • 4.9 Europe Market Y-o-Y Growth Rate Comparison 2016–2031
        • 4.10.1 Europe Market Y-o-Y Growth Rate by Region
        • 4.10.2 Europe Market Y-o-Y Growth Rate by Type
        • 4.10.3 Europe Market Y-o-Y Growth Rate by Dristribution Channel
        • 4.10.4 Europe Market Y-o-Y Growth Rate by End User
      • 4.11 Europe Market Share Comparison 2015–2030
        • 4.11.1 Europe Market Share by Region
        • 4.11.2 Europe Market Share by Type
        • 4.11.3 Europe Market Share by Dristribution Channel
        • 4.11.4 Europe Market Share by End User
    • Chapter 5 Asia-Pacific Diabetes Injection Pens Market Overview
      • 5.1 Asia-Pacific Market by Type
        • 5.1.1 Asia-Pacific Market Value & Volume Comparison by Type (2015-2031)
        • 5.1.2 Asia-Pacific Market Value & Volume Market Share by Type in 2021
      • 5.2 Asia-Pacific Market Value & Volume Comparison by Dristribution Channel (2015-2031)
        • 5.2.1 Asia-Pacific Market Value & Volume Market Share by Dristribution Channel in 2021
        • 5.2.2 Asia-Pacific Market Attractiveness Analysis by Dristribution Channel, 2015–2022
      • 5.3 Asia-Pacific Market by End User
        • 5.3.1 Asia-Pacific Market Value & Volume Comparison by End User (2015-2031)
        • 5.3.2 Asia-Pacific Market Value & Volume Market Share by End User in 2021
        • 5.3.3 Asia-Pacific Market Attractiveness Analysis by End User, 2015–2022
      • 5.4 Asia-Pacific Market Outlook by Region
        • 5.4.1 Asia-Pacific Market Value & Volume Comparison by Region (2015-2031)
        • 5.4.2 Asia-Pacific Market Value & Volume Market Share by Region in 2021
        • 5.4.3 Asia-Pacific Market Attractiveness Analysis by Region, 2015–2022
      • 5.5 Asia-Pacific Market Outlook (2015-2031)
        • 5.5.1 Asia-Pacific Market Value & Volume (2015–2022)
        • 5.5.2 Asia-Pacific Market Value & Volume (2023-2031)
      • 5.6 Asia-Pacific Market Value & Volume by Regions
        • 5.6.1 Asia-Pacific Market Value & Volume Comparison by Region (2015–2022)
        • 5.6.2 Asia-Pacific Market Value & Volume Comparison by Region (2023-2031)
      • 5.7 Asia-Pacific Market Value & Volume by Type
        • 5.7.1 Asia-Pacific Market Value & Volume Comparison by Type (2015–2022)
        • 5.7.2 Asia-Pacific Market Value & Volume Comparison by Type (2023-2031)
      • 5.8 Asia-Pacific Market Value & Volume by Dristribution Channel
        • 5.8.1 Asia-Pacific Market Value & Volume Comparison by Dristribution Channel (2015–2022)
        • 5.8.2 Asia-Pacific Market Value & Volume Comparison by Dristribution Channel (2023-2031)
      • 5.9 Asia-Pacific Market Value & Volume by End User
        • 5.9.1 Asia-Pacific Market Value & Volume Comparison by End User (2015–2022)
        • 5.9.2 Asia-Pacific Market Value & Volume Comparison by End User (2023-2031)
      • 5.10 Asia-Pacific Market Y-o-Y Growth Rate Comparison 2016–2031
        • 5.10.1 Asia-Pacific Market Y-o-Y Growth Rate by Region
        • 5.10.2 Asia-Pacific Market Y-o-Y Growth Rate by Type
        • 5.10.3 Asia-Pacific Market Y-o-Y Growth Rate by Dristribution Channel
        • 5.10.4 Asia-Pacific Market Y-o-Y Growth Rate by End User
      • 5.11 Asia-Pacific Market Share Comparison 2015–2030
        • 5.11.1 Asia-Pacific Market Share by Region
        • 5.11.2 Asia-Pacific Market Share by Type
        • 5.11.3 Asia-Pacific Market Share by Dristribution Channel
        • 5.11.4 Asia-Pacific Market Share by End User
    • Chapter 6 Latin America Diabetes Injection Pens Market Overview
      • 6.1 Latin America Market by Type
        • 6.1.1 Latin America Market Value & Volume Comparison by Type (2015-2031)
        • 6.1.2 Latin America Market Value & Volume Market Share by Type in 2021
      • 6.2 Latin America Market Value & Volume Comparison by Dristribution Channel (2015-2031)
        • 6.2.1 Latin America Market Value & Volume Market Share by Dristribution Channel in 2021
        • 6.2.2 Latin America Market Attractiveness Analysis by Dristribution Channel, 2015–2022
      • 6.3 Latin America Market by End User
        • 6.3.1 Latin America Market Value & Volume Comparison by End User (2015-2031)
        • 6.3.2 Latin America Market Value & Volume Market Share by End User in 2021
        • 6.3.3 Latin America Market Attractiveness Analysis by End User, 2015–2022
      • 6.4 Latin America Market Outlook by Region
        • 6.4.1 Latin America Market Value & Volume Comparison by Region (2015-2031)
        • 6.4.2 Latin America Market Value & Volume Market Share by Region in 2021
        • 6.4.3 Latin America Market Attractiveness Analysis by Region, 2015–2022
      • 6.5 Latin America Market Outlook (2015-2031)
        • 6.5.1 Latin America Market Value & Volume (2015–2022)
        • 6.5.2 Latin America Market Value & Volume (2023-2031)
      • 6.6 Latin America Market Value & Volume by Regions
        • 6.6.1 Latin America Market Value & Volume Comparison by Region (2015–2022)
        • 6.6.2 Latin America Market Value & Volume Comparison by Region (2023-2031)
      • 6.7 Latin America Market Value & Volume by Type
        • 6.7.1 Latin America Market Value & Volume Comparison by Type (2015–2022)
        • 6.7.2 Latin America Market Value & Volume Comparison by Type (2023-2031)
      • 6.8 Latin America Market Value & Volume by Dristribution Channel
        • 6.8.1 Latin America Market Value & Volume Comparison by Dristribution Channel (2015–2022)
        • 6.8.2 Latin America Market Value & Volume Comparison by Dristribution Channel (2023-2031)
      • 6.9 Latin America Market Value & Volume by End User
        • 6.9.1 Latin America Market Value & Volume Comparison by End User (2015–2022)
        • 6.9.2 Latin America Market Value & Volume Comparison by End User (2023-2031)
      • 6.10 Latin America Market Y-o-Y Growth Rate Comparison 2016–2031
        • 6.10.1 Latin America Market Y-o-Y Growth Rate by Region
        • 6.10.2 Latin America Market Y-o-Y Growth Rate by Type
        • 6.10.3 Latin America Market Y-o-Y Growth Rate by Dristribution Channel
        • 6.10.4 Latin America Market Y-o-Y Growth Rate by End User
      • 6.11 Latin America Market Share Comparison 2015–2030
        • 6.11.1 Latin America Market Share by Region
        • 6.11.2 Latin America Market Share by Type
        • 6.11.3 Latin America Market Share by Dristribution Channel
        • 6.11.4 Latin America Market Share by End User
    • Chapter 7 MEA Diabetes Injection Pens Market Overview
      • 7.1 MEA Market by Type
        • 7.1.1 MEA Market Value & Volume Comparison by Type (2015-2031)
        • 7.1.2 MEA Market Value & Volume Market Share by Type in 2021
      • 7.2 MEA Market Value & Volume Comparison by Dristribution Channel (2015-2031)
        • 7.2.1 MEA Market Value & Volume Market Share by Dristribution Channel in 2021
        • 7.2.2 MEA Market Attractiveness Analysis by Dristribution Channel, 2015–2022
      • 7.3 MEA Market by End User
        • 7.3.1 MEA Market Value & Volume Comparison by End User (2015-2031)
        • 7.3.2 MEA Market Value & Volume Market Share by End User in 2021
        • 7.3.3 MEA Market Attractiveness Analysis by End User, 2015–2022
      • 7.4 MEA Market Outlook by Region
        • 7.4.1 MEA Market Value & Volume Comparison by Region (2015-2031)
        • 7.4.2 MEA Market Value & Volume Market Share by Region in 2021
        • 7.4.3 MEA Market Attractiveness Analysis by Region, 2015–2022
      • 7.5 MEA Market Outlook (2015-2031)
        • 7.5.1 MEA Market Value & Volume (2015–2022)
        • 7.5.2 MEA Market Value & Volume (2023-2031)
      • 7.5 MEA Market Value & Volume by Regions
        • 7.6.1 MEA Market Value & Volume Comparison by Region (2015–2022)
        • 7.6.2 MEA Market Value & Volume Comparison by Region (2023-2031)
      • 7.7 MEA Market Value & Volume by Type
        • 7.7.1 MEA Market Value & Volume Comparison by Type (2015–2022)
        • 7.7.2 MEA Market Value & Volume Comparison by Type (2023-2031)
      • 7.8 MEA Market Value & Volume by Dristribution Channel
        • 7.8.1 MEA Market Value & Volume Comparison by Dristribution Channel (2015–2022)
        • 7.8.2 MEA Market Value & Volume Comparison by Dristribution Channel (2023-2031)
      • 7.9 MEA Market Value & Volume by End User
        • 7.9.1 MEA Market Value & Volume Comparison by End User (2015–2022)
        • 7.9.2 MEA Market Value & Volume Comparison by End User (2023-2031)
      • 7.10 MEA Market Y-o-Y Growth Rate Comparison 2016–2031
        • 7.10.1 MEA Market Y-o-Y Growth Rate by Region
        • 7.10.2 MEA Market Y-o-Y Growth Rate by Type
        • 7.10.3 MEA Market Y-o-Y Growth Rate by Dristribution Channel
        • 7.10.4 MEA Market Y-o-Y Growth Rate by End User
      • 7.11 MEA Market Share Comparison 2015–2030
        • 7.11.1 MEA Market Share by Region
        • 7.11.2 MEA Market Share by Type
        • 7.11.3 MEA Market Share by Dristribution Channel
        • 7.11.4 MEA Market Share by End User
    • Chapter 8 Global Diabetes Injection Pens Market Company Profiles
      • 8.1 Market Competition Scenario Analysis, By Company
      • 8.2 Competitor Landscape
      • 8.3 Company Share Analysis
      • 8.4 Company Profiles
        • 8.4.1 AstraZeneca PLC
          • 8.4.1.1 Company Overview
          • 8.4.1.2 Business Description
          • 8.4.1.3 Product Portfolio
          • 8.4.1.4 Key Financials
          • 8.4.1.5 Key Developments
          • 8.4.1.6 SWOT Analysis
        • 8.4.2 Becton, Dickinson, and Company
          • 8.4.2.1 Company Overview
          • 8.4.2.2 Business Description
          • 8.4.2.3 Product Portfolio
          • 8.4.2.4 Key Financials
          • 8.4.2.5 Key Developments
          • 8.4.2.6 SWOT Analysis
        • 8.4.3 SANOFI
          • 8.4.3.1 Company Overview
          • 8.4.3.2 Business Description
          • 8.4.3.3 Product Portfolio
          • 8.4.3.4 Key Financials
          • 8.4.3.5 Key Developments
          • 8.4.3.6 SWOT Analysis
        • 8.4.4 Biocon Ltd.
          • 8.4.4.1 Company Overview
          • 8.4.4.2 Business Description
          • 8.4.4.3 Product Portfolio
          • 8.4.4.4 Key Financials
          • 8.4.4.5 Key Developments
          • 8.4.4.6 SWOT Analysis
        • 8.4.5 Eli Lilly and Company
          • 8.4.5.1 Company Overview
          • 8.4.5.2 Business Description
          • 8.4.5.3 Product Portfolio
          • 8.4.5.4 Key Financials
          • 8.4.5.5 Key Developments
          • 8.4.5.6 SWOT Analysis
        • 8.4.6 Jiangsu Delfu medical device Co., Ltd.
          • 8.4.6.1 Company Overview
          • 8.4.6.2 Business Description
          • 8.4.6.3 Product Portfolio
          • 8.4.6.4 Key Financials
          • 8.4.6.5 Key Developments
          • 8.4.6.6 SWOT Analysis
        • 8.4.7 Novo Nordisk A/S
          • 8.4.7.1 Company Overview
          • 8.4.7.2 Business Description
          • 8.4.7.3 Product Portfolio
          • 8.4.7.4 Key Financials
          • 8.4.7.5 Key Developments
          • 8.4.7.6 SWOT Analysis
        • 8.4.8 Owen Mumford Ltd.
          • 8.4.8.1 Company Overview
          • 8.4.8.2 Business Description
          • 8.4.8.3 Product Portfolio
          • 8.4.8.4 Key Financials
          • 8.4.8.5 Key Developments
          • 8.4.8.6 SWOT Analysis
        • 8.4.9 Wockhardt Ltd.
          • 8.4.9.1 Company Overview
          • 8.4.9.2 Business Description
          • 8.4.9.3 Product Portfolio
          • 8.4.9.4 Key Financials
          • 8.4.9.5 Key Developments
          • 8.4.9.6 SWOT Analysis
        • 8.4.11 Other Key Players
    • Chapter 9 Research Methodology
      • 9.1 Research Methodology
      • 9.2 Primary Research
      • 9.3 Secondary Research
      • 9.4 Report Scope
    • Chapter 10 About Us
      • 10.1 Who we are:
    • Chapter 11 Disclaimer

    To learn more about this report, request for sample report

  • Inquiry Form

    • I wish to see a sample of this report because.




    • Request for Customization

    Why Choose Us

    • 360 Degree Approach
    • Growth Consulting
    • 24/7 Research Support
    • Comprehensive-Level of Customization
    • Comprehensive-Level of Customization
    • Competitive Intelligence
    • Single-Country/ Region Intelligence
    • Post-Sale Service Assistance
    • Access to Lead Analysts
    • Available in PDF, Excel, Word/ PPT

  • Request for Customization

    • I wish to see a sample of this report because.




    • Request for Customization

RELATED REPORTS

OUR CLIENTS

Don't just take our word. We are trusted by these great companies!

MARKET RESEARCH REPORTS

MarketResearch.biz (Powered by Prudour Pvt. Ltd.) delivers customized research solutions by actuating its broad spectrum of research methodologies, databases, and resources, and this is further strengthened by our global experience in syndicated and customized industry projects.

Our tailor-made research services include quick market scans, country reports, in-depth market analysis, competition monitoring, consumer research and satisfaction studies, supplier research, growth planning, and quite a lot more.

SHORT NAVIGATION

CONTACT US

Copyright © 2023 MarketResearch.biz. All Rights Reserved.

Powered by Pvt. Ltd.